Mass layoffs at the inventor of aspirin show that Bayer, the German maker of drugs and seeds, has more headaches than its Monsanto hangover. The conglomerate’s health care division, which provides more than half its revenue, needs urgent attention. Bayer will begin losing patent protection for two blockbuster drugs in the next five years and has little under development to compensate.

Sections:  u.s.   
Topics:  Maine   Penobscot County   Bangor   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News